See Which Of The Latest 13F Filers Holds JNJ

Aggregate 13F filings for the 06/30/2025 reporting period reveal institutional investors collectively increased their long positions in Johnson & Johnson (JNJ) by 907,641 shares, a 0.38% rise to 239,913,785 total shares. This modest aggregate increase in institutional ownership suggests a stable or slightly growing conviction in JNJ among a broad base of funds, underscoring the value of analyzing overall positioning despite the limited scope of 13F disclosures.

Analysis

An analysis of 13F filings for the period ending June 30, 2025, reveals nuanced institutional sentiment towards Johnson & Johnson (JNJ). While aggregate data across 4,215 funds indicates a modest 0.38% increase in total shares held to 239.9 million, a closer examination of a recent 23-filer sample presents a more mixed picture, with nine funds decreasing positions versus five increasing them. The headline aggregate share increase is significantly skewed by a single large purchase from Geode Capital Management LLC, which added over 1.2 million shares. Critically, despite this substantial share addition, the market value of Geode's holding and the aggregate sample's holding decreased by $598.8 million and $588.5 million respectively. This divergence between a rising share count and falling market value strongly suggests that JNJ's stock price declined during the quarter, indicating that institutional buying may be a "buy-the-dip" strategy rather than a reflection of broad-based bullish momentum.

Key Decisions for Investors

• Investors should view the marginal 0.38% aggregate increase in institutional ownership with caution, recognizing it is heavily influenced by a few large buyers and does not reflect widespread new conviction.
• The divergence between increased share counts and decreased market value suggests institutions may have been accumulating shares into price weakness, a factor to weigh when assessing the quality of institutional support.
• Given that 13F filings only capture long positions and the sample data is mixed, this positioning data should be used to supplement, not replace, fundamental analysis on JNJ's core business and valuation.